No Appeal of LDT/FDA Lawsuit

No Appeal of LDT/FDA Lawsuit

The FDA had until May 30 to appeal U.S. District Court Judge Sean D. Jordan's decision to vacate the agency's Final Rule seeking to regulate laboratory developed tests (LDTs). The federal government declined to appeal the judge's decision meaning the Texas District Court's decision to vacate, in its entirety, the FDA's attempt to regulate LDTs as medical devices stands.

Read ACLA’s full lawsuit.

Read the Final Judgment.

 

CMS, CDC, and HHS Seek Public Input on Potential CLIA Updates

CMS, CDC, and HHS Seek Public Input on Potential CLIA Updates

Centers for Medicare & Medicaid Services (CMS), Centers for Disease Control and Prevention (CDC), and the Department of Health and Human Services...

Read More
White Paper: The in-house vs. outsourced billing questions answered

White Paper: The in-house vs. outsourced billing questions answered

Most labs answer them as one, and that is what makes the decision expensive. Separating them is what makes it reversible. BY TELCOR WITH KWAMI...

Read More
CMS Releases October Quarterly Update to CLFS and CLIA HCPCS Codes

CMS Releases October Quarterly Update to CLFS and CLIA HCPCS Codes

The Centers for Medicare & Medicaid Services (CMS) posted the October 2026 Quarterly Update to the Clinical Laboratory Fee Schedule (CLFS) and...

Read More